SynPlexity

Transforming synthetic biology with precise, cost-effective gene libraries.

EUGENE, United States · Founded 2024

Headquarters
EUGENE, Oregon
Employees
1–10
Founded
2024
Business Model
B2B
Last Round
Pre-SeedJan 2024
Rounds
1

About

SynPlexity enables researchers to scale biology with multiplexed DNA libraries — delivering more variants, faster discovery, and lower cost using proprietary DropSynth microreactor technology. The platform serves protein engineering, drug discovery, and functional genomics workflows, providing gene libraries up to 25,000+ fragments with in-house NGS quality control.

Summary

SynPlexity is an Artificial Intelligence company based in EUGENE, United States, founded in 2024. Its most recent funding was a Pre-Seed round in Jan 2024. Investors include Portland Seed Fund and SOSV.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Pre-seedPre-SeedJan 2024

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

SynPlexity on Indexed.vc
<a href="https://indexed.vc/companies/synplexity"><img src="https://indexed.vc/api/badge/company/synplexity" alt="SynPlexity on Indexed.vc" width="260" height="76" /></a>